<DOC>
	<DOC>NCT00700765</DOC>
	<brief_summary>This study is conducted in Asia. The aim of this observational study is to evaluate the incidence of adverse events while using Levemir速 under normal clinical practice conditions.</brief_summary>
	<brief_title>Observational Study to Evaluate Safety of Levemir速 in Type 1 and Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Type 1 or type 2 diabetes mellitus Subjects who are unlikely to comply with the protocol Subjects who are currently being treated with Levemir速 Subjects who previously were enrolled into the study Subjects with hypersensitivity to Levemir速 or any of its excipients</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>